
Rebecca A Shilling MD
Critical Care Medicine, Pleural Disease
argenx Pharmaceuticals, Boston MA
Join to View Full Profile
909 S. Wolcott St. MC719COMRB Rm. 3055Chicago, IL 60612
Phone+1 312-355-4597
Dr. Shilling is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 2001 - 2004
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1997 - 2000
- Case Western Reserve University School of MedicineClass of 1997
Certifications & Licensure
- IL State Medical License 2000 - 2020
Publications & Presentations
PubMed
- 16 citationsGut Microbiota Can Impact Chronic Murine Lung Allograft Rejection.Qiang Wu, Benjamin A. Turturice, Sarah R. Wagner, Yue Huang, Pawan Kumar Gupta
American Journal of Respiratory Cell and Molecular Biology. 2019-01-01 - 191 citationsVX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del AllelesJane C. Davies, Samuel M. Moskowitz, Cynthia A. Brown, Alex Horsley, Marcus A. Mall
The New England Journal of Medicine. 2018-10-18 - 24 citationsIL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.Pawan Kumar Gupta, Sarah R. Wagner, Qiang Wu, Rebecca A. Shilling
American Journal of Respiratory Cell and Molecular Biology. 2017-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: